Atanasov Atanas H

CFO Atanasov buys 5,000 DINO shares at $33.77; stock down 47.2% from 52-week high.

Atanasov Atanas H, EVP and CFO, purchased 5,000 shares at $33.77 on 2024-12-19, bringing total holdings to 78,927 shares. This marks the third consecutive open-market purchase at DINO within one week (prior buys on 2024-12-13 and 2024-12-12), yet these recent trades remain too new to assess their outcome. The stock has declined 47.2% from its 52-week high of $63.71 and is down 20.4% over the past 30 days, creating substantial downside pressure from recent entry points. Fundamentally, the company reported a net loss of $75,944,000 in the latest quarter, a 16.3% revenue decline year-over-year, and maintains a P/E of 19.35 despite negative earnings; the three consecutive insider purchases in tight succession suggest accumulation activity, but the lack of measurable outcomes on earlier same-ticker trades and the company's profitability headwinds limit the interpretive weight of this signal at this time.

CFO Atanasov purchases 9,000 shares ($340.6K) in 2 transactions at $37.96 and $37.46; stock down 44.1% from 52-week high

EVP and CFO Atanas H Atanasov made two open-market purchases totaling 9,000 shares for $340,624.40 on consecutive days (December 12–13, 2024) at prices of $37.96 and $37.46, increasing his holdings by 13.9%. The timing of this purchase occurs against a backdrop of significant price pressure: the stock is trading at $35.60, down 44.1% from its 52-week high of $63.71 and down 15.6% over the prior 30 days and 23.5% over 90 days. Simultaneously, the company reported a net loss of $75,944,000 in the latest quarter and annual revenue declined 16.3% year-over-year, indicating challenging operational and financial conditions. The CFO's purchase at elevated prices relative to the current market level ($37.85 blended average vs. $35.60 current) in the context of deteriorating fundamentals and substantial stock price decline warrants observation of whether this reflects confidence in near-term recovery or other factors.